An improvement of 20% was seen in 48% of the subjects receiving rotigotine and in 19% of the subjects receiving placebo (Difference 29% CI95% 18%; 39%, p < 0.0001).
20% - line paranemine oli näha 48% - l rotigotiini saanud patsientidel ja 19% - l platseebot saanud patsientidel (erinevus 29% CI95% 18%; 39%, p < 0, 0001).